Business Context and Reporting Period
Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2006
Business Overview: NAI operates in two primary segments: private label contract manufacturing for nutritional supplements and branded products (including the Real Health Laboratories and Dr. Cherry Pathway to Healing lines). The company recently integrated operations following the acquisition of Real Health Laboratories (RHL) in December 2005.
Key Financial Metrics
| Metric | Q1 2007 (Sep 30, 2006) | Q1 2006 (Sep 30, 2005) |
|---|---|---|
| Net Sales | $25,161,000 | $21,900,000 |
| Gross Profit | $5,515,000 | $4,056,000 |
| Gross Margin | 21.9% | 18.5% |
| Operating Income | $832,000 | $678,000 |
| Net Income | $387,000 | $412,000 |
| Diluted EPS | $0.05 | $0.06 |
| Operating Cash Flow | $7,661,000 | $3,849,000 |
| Total Debt (Outstanding) | $8,264,000 | $15,900,000 (Jun 30, 2006) |
| Cash and Equivalents | $2,000,000 | $2,157,000 (Jun 30, 2006) |
Note: Debt figures represent the sum of the line of credit ($2.3M) and term loans ($6.0M) as of September 30, 2006.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15% year-over-year. Branded products sales surged 107% due to the RHL acquisition, while private label contract manufacturing grew 6%.
- Profitability: Operating income rose 23% to $832,000. However, net income declined 6% to $387,000, primarily due to increased interest expense ($230,000 vs. $58,000) related to the RHL acquisition financing and carrying costs for new customer inventory.
- Margin Expansion: Gross margin improved by 3.4 percentage points, driven by RHL operations and lower inventory reserves, partially offset by higher overhead and labor costs.
- Debt Reduction: Consolidated debt decreased significantly from $15.9 million at June 30, 2006, to $8.3 million at September 30, 2006, due to substantial payments on the working capital line of credit.
- Cash Flow: Operating cash flow doubled to $7.7 million, largely driven by a $6.4 million collection of accounts receivable from prior quarter sales.
Guidance, Outlook, and Risks
Management Commentary: Management views the RHL acquisition as a strategic advance to diversify sales and expand distribution channels. While revenue growth is positive, the company anticipates quarterly fluctuations based on customer order timing. Future cost savings from operational integration are expected to be reinvested into marketing branded products.
Outlook: The company expects to continue its long-term trend of annual revenue growth but cautions that new customer relationships may not generate future sales at expected levels.
Risks and Contingencies:
- Customer Concentration: Two customers accounted for 70% of total net sales in Q1 2007 (down from 82% in the prior year). The loss of either customer would have a material adverse impact.
- Supplier Concentration: The company relies on a limited number of raw material suppliers.
- Market Risk: Exposure to foreign currency fluctuations (Euro and Swiss Franc) and interest rate increases on variable-rate debt.
- Legal: No material pending legal proceedings as of November 1, 2006.
Investor Verification Checklist
- Customer Dependency: Verify the stability of the top two customers (Customer 1 and Customer 2) representing 70% of sales.
- Debt Covenants: Review the amended credit facility terms, specifically the fixed charge coverage ratio and capital expenditure limits.
- Interest Expense Impact: Assess the sustainability of net income given the 752% increase in other expenses (primarily interest) compared to the prior year.
- Accounts Receivable: Monitor Days Sales Outstanding (69 days in Q1 2007 vs. 60 days prior year) to ensure collection trends remain healthy.
- Foreign Exchange Hedging: Review the status of the $8.9 million notional amount of option contracts used to hedge Euro exposure.